VYNE Therapeutics (VYNE) Return on Sales (2017 - 2026)

VYNE Therapeutics' Return on Sales history runs 10 years deep, the most recent figure standing at 0.0% for Q1 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales was 0.0% for Q1 2026 at VYNE Therapeutics, up from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.75% in Q1 2022 and bottomed at 0.75% in Q4 2022.
• A 5-year average of 0.01% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2022 — Return on Sales soared 117 bps — and 2023, when it plunged 75 bps.
• VYNE Therapeutics' Return on Sales stood at 0.75% in 2022, then soared by 99 bps to 0.0% in 2023, then jumped by 80 bps to 0.0% in 2024, then rose by 17 bps to 0.0% in 2025, then jumped by 57 bps to 0.0% in 2026.
• Business Quant data shows VYNE's Return on Sales at 0.0% in Q1 2026, 0.0% in Q2 2025, and 0.0% in Q1 2025.